Press Release: Shorla Oncology Welcomes Rayna Sethi Herman as Chief Commercial Officer December 8th 2023 Read More
PRESS RELEASE: Shorla Oncology Announces US Acquisition of Jylamvo, an Oncology and Autoimmune Drug from Therakind October 31st 2023 Read More
Raising Funds in a Tight Market: Q&A With Sharon Cunningham, CEO of Shorla Oncology October 24th 2023 Read More